In relapsing-remitting multiple sclerosis, activation of the peripheral immune system can lead to focal inflammation within the CNS. Over the past three decades, therapeutic development has been ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

In this week’s edition of InnovationRx, we look at how Daniel Nadler became a billionaire building a ChatGPT for doctors, big news from two Chinese biotech companies, what doctors think about AI and ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Earlier, in January 2025, the FDA released a companion piece of draft guidance titled “Considerations for the Use of ...

Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 ...

Hosted by Republican Sen. Dave McCormick, the conference will be held at Carnegie Mellon University as Pennsylvania leaders ...

OpenAI, Alphabet’s Google, Anthropic and Elon Musk’s AI company xAI have won contracts of up to $200 million each, aimed at scaling up adoption of advanced artificial intelligence capabilities in the ...

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

OpenAI, Alphabet's Google , Anthropic and Elon Musk's AI firm xAI have won contracts of up to $200 million each, aimed at ...

Most U.S. adults find the information to be at least somewhat reliable, new research shows. But experts say there is ...